美国OTC市场Neximmune, Inc.盘中异动快速拉升10.89%报0.111美元

市场透视2025-02-08

北京时间2025年02月08日01时06分，美国OTC市场Neximmune, Inc.（NEXI.us）股票出现波动，股价急速上涨10.89%。截至发稿，该股报0.111美元/股，成交量404股，换手率0.03%，振幅0.00%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-2.33百万美元，每股收益-1.69美元，毛利-75408.00美元，市盈率-0.01倍。机构评级方面，在所有...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2509947729?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-02-08 01:06","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2509947729","market":"us","top_or_hot":-1,"title":"美国OTC市场Neximmune, Inc.盘中异动 快速拉升10.89%报0.111美元","media":"市场透视","content":"<div>\n<p>北京时间2025年02月08日01时06分，美国OTC市场Neximmune, Inc.（NEXI.us）股票出现波动，股价急速上涨10.89%。截至发稿，该股报0.111美元/股，成交量404股，换手率0.03%，振幅0.00%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-2.33百万美元，每股收益-1.69美元，毛利-75408.00美元，市盈率-0.01倍。机构评级方面，在所有...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208010601a23d44dd&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>美国OTC市场Neximmune, Inc.盘中异动 快速拉升10.89%报0.111美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n美国OTC市场Neximmune, Inc.盘中异动 快速拉升10.89%报0.111美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-02-08 01:06 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208010601a23d44dd&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2025年02月08日01时06分，美国OTC市场Neximmune, Inc.（NEXI.us）股票出现波动，股价急速上涨10.89%。截至发稿，该股报0.111美元/股，成交量404股，换手率0.03%，振幅0.00%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-2.33百万美元，每股收益-1.69美元，毛利-75408.00美元，市盈率-0.01倍。机构评级方面，在所有...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208010601a23d44dd&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208010601a23d44dd&s=b","article_id":"2509947729","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208010601a23d44dd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2509947729","pubTimestamp":1738947961,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2025年02月08日01时06分，美国OTC市场Neximmune, Inc.股票出现波动，股价急速上涨10.89%。截至发稿，该股报0.111美元/股，成交量404股，换手率0.03%，振幅0.00%。美国OTC市场Neximmune, Inc.股票所在的生物技术行业中，整体跌幅为0.49%。美国OTC市场Neximmune, Inc.公司简介：NexImmune Inc 是一家临床阶段的生物技术公司，开发一种新的免疫治疗方法，旨在利用人体的 T 细胞产生抗原特异性细胞介导的免疫反应，对患者具有治疗潜力。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4139":"生物科技","NEXI":"NexImmune, Inc."},"translate_title":"Neximmune, Inc. in the U.S. OTC market rose 10.89% to $0.111 after intraday changes","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NEXI":1},"content_text":"北京时间2025年02月08日01时06分，美国OTC市场Neximmune, Inc.（NEXI.us）股票出现波动，股价急速上涨10.89%。截至发稿，该股报0.111美元/股，成交量404股，换手率0.03%，振幅0.00%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-2.33百万美元，每股收益-1.69美元，毛利-75408.00美元，市盈率-0.01倍。机构评级方面，在所有1家参与评级的机构中，100%的券商给予持有建议，无券商给予买入、卖出建议。美国OTC市场Neximmune, Inc.股票所在的生物技术行业中，整体跌幅为0.49%。其相关个股中，Conduit Pharmaceuticals Inc.、Nutriband Inc C/Wts (To Pur Com)、Conduit Pharmaceuticals Inc C/Wts 22/09/2028(To Pur Com)涨幅较大，Conduit Pharmaceuticals Inc.、Tonix Pharmaceuticals Holding Corp.、Lipella Pharmaceuticals Inc.较为活跃，换手率分别为5817.07%、169.96%、105.94%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 (To Pur Com)、Conduit Pharmaceuticals Inc.、Tonix Pharmaceuticals Holding Corp.，振幅分别为130.43%、74.19%、53.38%。美国OTC市场Neximmune, Inc.公司简介：NexImmune Inc 是一家临床阶段的生物技术公司，开发一种新的免疫治疗方法，旨在利用人体的 T 细胞产生抗原特异性细胞介导的免疫反应，对患者具有治疗潜力。 它为癌症和其他危及生命的免疫介导疾病患者创造了具有治愈潜力的疗法。 该公司有两种候选产品正在进行人体试验：用于治疗急性髓系白血病（AML）的 NEXI-001 和用于治疗多发性骨髓瘤（MM）的 NEXI-002。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2509947729","isCrawlerRequest":true}

美国OTC市场Neximmune, Inc.盘中异动 快速拉升10.89%报0.111美元

精彩评论

美国OTC市场Neximmune, Inc.盘中异动快速拉升10.89%报0.111美元